or Try an Advanced Search...

    Blastoma Stocks List

    Symbol Grade Name % Change
    NVCR D NovoCure Limited 6.80
    AFMD D Affimed Therapeutics B.V. 0.57
    KZIA F Kazia Therapeutics Limited -2.10
    AEZS F AEterna Zentaris Inc. 2.55
    PRLD F Prelude Therapeutics Incorporated 1.61
    CNSP F CNS Pharmaceuticals, Inc. 1.94
    MBRX F Moleculin Biotech, Inc. -0.84
    SGMO F Sangamo BioSciences, Inc. 2.24
    TCON F TRACON Pharmaceuticals, Inc. 0.19
    View As Page of Charts
    Related Industries: Biotechnology Medical Instruments & Supplies
    Related Stock Lists: Cancer Glioblastoma Medicine Biopharmaceutical Oncology Clinical Development Lymphoma Solid Tumors Biotechnology Brain Tumor Chemotherapy Glioma Neuroblastoma Ovarian Cancer Prostate Cancer Stage Pharmaceutical Transcription Transcription Factor Transcription Factors ATM

    Related ETFs - A few ETFs which own one or more of the above listed Blastoma stocks.

    Symbol Grade Name Weight
    BBP D BioShares Biotechnology Products Fund 3.15
    SBIO D ALPS Medical Breakthroughs ETF 3.0
    PBE C PowerShares Dynamic Biotech & Genome 2.9
    MRGR C ProShares Merger ETF 2.5
    CNCR D Loncar Cancer Immunotherapy ETF 2.09
    View all Blastoma ETFs...
    Compare ETFs
    Compare BBP to PBE Compare MRGR to CNCR Compare SBIO to MRGR

        Blastoma Stocks Recent News

        Date Stock Title
        May 12 SGMO US$3.50 - That's What Analysts Think Sangamo Therapeutics, Inc. (NASDAQ:SGMO) Is Worth After These Results
        May 12 SGMO Sangamo Therapeutics, Inc. (NASDAQ:SGMO) Q1 2024 Earnings Call Transcript
        May 11 SGMO Sangamo Therapeutics First Quarter 2024 Earnings: US$0.27 loss per share (vs US$0.13 profit in 1Q 2023)
        May 10 SGMO Sangamo Therapeutics Reports Q1 2024 Results: A Deep Dive into Financials and Strategic Highlights
        May 9 SGMO Sangamo Therapeutics, Inc. (SGMO) Q1 2024 Earnings Call Transcript
        May 9 CNSP CNS Pharmaceuticals files for $75M mixed shelf offering
        May 9 SGMO Sangamo Therapeutics (SGMO) Reports Q1 Loss, Lags Revenue Estimates
        May 9 SGMO Sangamo Therapeutics GAAP EPS of -$0.27 misses by $0.05, revenue of $0.48M misses by $5.88M
        May 9 SGMO Sangamo Therapeutics Reports Recent Business Highlights and First Quarter 2024 Financial Results
        May 9 MBRX Moleculin Announces U.S. Patent Issue Notification for Lipid-Based Delivery Technology for Annamycin
        May 9 SGMO Sangamo Therapeutics Presents Next-Generation Modular Integrase Technology Engineered to Enable Large-Scale Genome Editing
        May 9 PRLD Prelude Therapeutics to Participate in Citizens JMP Life Sciences Conference
        May 8 SGMO Sangamo Therapeutics Q1 2024 Earnings Preview
        May 8 MBRX Moleculin to Report First Quarter 2024 Financial Results on May 10, 2024 and Host Conference Call and Webcast
        May 7 TCON TRACON to Report First Quarter 2024 Financial Results and Provide Corporate Update on May 14, 2024
        May 7 MBRX Moleculin Reports Higher AML Complete Remission (CR) Rates and Significant Durability with Additional Interim Subject Data
        May 7 PRLD Prelude Therapeutics GAAP EPS of -$0.42
        May 7 PRLD Prelude Therapeutics Reports First Quarter 2024 Financial Results and Provides Corporate Update
        Related Industries: Biotechnology Medical Instruments & Supplies
        Related Stock Lists: Cancer Glioblastoma Medicine Biopharmaceutical Clinical Development Oncology Solid Tumors Brain Tumor Cancer Treatment Biotechnology Chemotherapy Neuroblastoma Antineoplastic Drugs CD19 Cancer Cell Chronic Lymphocytic Leukemia Clinical Medicine Glioblastoma Multiforme Glioma Hematologic Malignancies
        Blastoma

        A blastoma is a type of cancer, more common in children, that is caused by malignancies in precursor cells, often called blasts. Examples are nephroblastoma, medulloblastoma, and retinoblastoma. The suffix -blastoma is used to imply a tumor of primitive, incompletely differentiated (or precursor) cells, e.g., chondroblastoma is composed of cells resembling the precursor of chondrocytes.

        More about Blastoma
        Browse All Tags